V CompBrief BY VELARION

Independent Director · Spyre Therapeutics, Inc. (SYRE)

Chair, Compensation Committee

Jeffrey Albers director compensation at Spyre Therapeutics: $349K

Fiscal year 2025 director compensation for Jeffrey Albers at Spyre Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 10, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Jeffrey Albers’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Jeffrey Albers and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Spyre Therapeutics Director Compensation Table · the one fiscal year held
In US dollars, as Spyre Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$100,000$0$248,675$0$348,675

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Spyre Therapeutics, Inc. DEF 14A filed April 10, 2026, accession 0001636282-26-000039, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Spyre Therapeutics, Inc. filed document, accession 0001636282-26-000039. Every figure is read from that document and cited to the page and table it appears in. Filed April 10, 2026.

Get the Spyre Therapeutics Board Governance Report

$348,675 Jeffrey Albers, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 10, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Spyre Therapeutics pays directors a $40,000 cash retainer and $350,000 in equity.

Committees

FY2025 · as the proxy prints them

Audit · Compensation (Chair)

The rest of the Spyre Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Cameron TurtleDirector—
Laurie StelzerIndependent Director$313,675
Mark McKennaDirector$288,675
Michael HendersonIndependent Director$298,675
Peter HarwinIndependent Director$293,675
Sandra MilliganIndependent Director$306,175
Tomas KiselakIndependent Director$296,175

The full Spyre Therapeutics compensation record

free company brief
Spyre Therapeutics, Inc. (SYRE) — free Compensation Briefevery named executive and director, board pay, say-on-pay, the peer group

This page is one director within Spyre Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the Spyre Therapeutics proxy · each links to its own free brief

Order SYRE

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report